Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease

Clinical trial NCT00349752 · TERMINATED

Trial details

NCT number: NCT00349752
Sponsor: UCB Pharma
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2006-11-01
Primary completion: 2009-07-01
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.